bluebird bio, Inc. (BLUE)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.31 |
| Open | 6.39 |
| Bid | 6.95 x 3100 |
| Ask | 6.96 x 4000 |
| Day's range | 6.33 - 7.00 |
| 52-week range | 2.87 - 17.85 |
| Volume | |
| Avg. volume | 8,080,754 |
| Market cap | 471.121M |
| Beta (5Y monthly) | 1.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -12.82 |
| Earnings date | 21 Feb 2022 - 25 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.33 |
- Zacks
bluebird (BLUE) Q2 Loss Narrower Than Expected, Sales Miss
bluebird (BLUE) posts a narrower-than-expected loss in the second quarter. However, sales miss estimates.
- Zacks
Bluebird Bio (BLUE) Reports Q2 Loss, Lags Revenue Estimates
Bluebird (BLUE) delivered earnings and revenue surprises of 1.53% and 76.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
bluebird bio Reports Second Quarter 2022 Financial Results and Highlights Operational Progress
SOMERVILLE, Mass, August 04, 2022--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported financial results and business highlights for the second quarter ended June 30, 2022, and shared recent operational progress.
© 2022 Yahoo. All rights reserved.
